EPS for IntelliPharmaCeutics International Inc. (IPCI) Expected At $-0.07; Robecosam Ag Raised Cognizant Technology Solutio (CTSH) Stake By $525,200

June 10, 2018 - By Marie Mckinney

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) Logo

Analysts expect IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) to report $-0.07 EPS on July, 10.They anticipate $0.01 EPS change or 16.67% from last quarter’s $-0.06 EPS. After having $-0.09 EPS previously, IntelliPharmaCeutics International Inc.’s analysts see -22.22% EPS growth. The stock increased 3.51% or $0.0144 during the last trading session, reaching $0.4244. About 1.21 million shares traded or 354.36% up from the average. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has declined 78.43% since June 10, 2017 and is downtrending. It has underperformed by 91.00% the S&P500. Some Historical IPCI News: ; 14/03/2018 INTELLIPHARMACEUTICS TO END CONTINUOUS OFFERING DATED JULY 2017; 19/03/2018 – INTELLIPHARMACEUTICS INTERNATIONAL- THE OFFERING IS IN ADDITION TO OFFERING FOR GROSS PROCEEDS OF ABOUT US$3.5 MILLION WHICH WAS PREVIOUSLY ANNOUNCED; 20/03/2018 – ANSON FUNDS MANAGEMENT LP REPORTS 7.2 PCT PASSIVE STAKE IN INTELLIPHARMACEUTICS INTERNATIONAL INC AS OF MARCH 14, 2018 – SEC FILING; 23/04/2018 – INTELLIPHARMACEUTICS INTERNATIONAL SAYS RECEIVED LETTER FROM NASDAQ TO DELIST THE COMPANY’S SECURITIES FROM NASDAQ – SEC FILING

Robecosam Ag increased Cognizant Technology Solutio (CTSH) stake by 5.01% reported in 2018Q1 SEC filing. Robecosam Ag acquired 6,565 shares as Cognizant Technology Solutio (CTSH)’s stock declined 8.67%. The Robecosam Ag holds 137,482 shares with $11.07M value, up from 130,917 last quarter. Cognizant Technology Solutio now has $45.18 billion valuation. The stock increased 0.51% or $0.39 during the last trading session, reaching $77.11. About 2.08M shares traded. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 13.31% since June 10, 2017 and is uptrending. It has outperformed by 0.74% the S&P500. Some Historical CTSH News: ; 14/05/2018 – IDP Education Partners with Cognizant to Help Students Realise Their International Study and Career Goals; 07/05/2018 – COGNIZANT SEES 2Q ADJ EPS AT LEAST $1.09, EST. $1.12; 07/05/2018 – Cognizant Tech Solutions Sees FY Adj EPS $4.47; 12/03/2018 Cognizant To Acquire Bolder Healthcare Solutions To Expand Revenue Cycle Management Services For Providers; 22/03/2018 – Accenture has spent more than $3 billion over the last three, years nearly half of it in fiscal 2017 on some 70 acquisitions, to boost its digital and cloud services in order to compete better with Cognizant and IBM; 03/04/2018 – COGNIZANT SAYS HIGH COURT LIFTS ATTACHMENT OF CTSH ACCOUNTS; 07/05/2018 – Cognizant Tech Solutions 1Q Adjusted Operating Margin 20.3%; 07/05/2018 – Cognizant Tech Solutions 1Q Net $520M; 03/04/2018 – Indian court orders tax dept to lift freeze on Cognizant’s funds; 01/05/2018 – Cognizant Launches U.S. Foundation to Empower Digital Education and Skills Training Initiatives Across the United States

Another recent and important Cognizant Technology Solutions Corporation (NASDAQ:CTSH) news was published by Seekingalpha.com which published an article titled: “STMicroelectronics Is Inexpensive – Cramer’s Lightning Round (6/1/18)” on June 04, 2018.

Robecosam Ag decreased Alphabet Inc stake by 292 shares to 5,718 valued at $5.93M in 2018Q1. It also reduced General Mls Inc (NYSE:GIS) stake by 7,698 shares and now owns 7,875 shares. Air Prods & Chems Inc (NYSE:APD) was reduced too.

Among 33 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 26 have Buy rating, 1 Sell and 6 Hold. Therefore 79% are positive. Cognizant Technology Solutions Corp. has $100.0 highest and $48 lowest target. $83.65’s average target is 8.48% above currents $77.11 stock price. Cognizant Technology Solutions Corp. had 92 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Outperform” on Tuesday, February 9. The firm has “Outperform” rating given on Thursday, August 6 by BMO Capital Markets. Citigroup downgraded the shares of CTSH in report on Friday, September 30 to “Neutral” rating. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has “Buy” rating given on Friday, October 16 by Cantor Fitzgerald. The rating was maintained by BMO Capital Markets on Thursday, August 3 with “Buy”. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has “Buy” rating given on Tuesday, September 5 by RBC Capital Markets. The rating was initiated by Cowen & Co on Friday, February 19 with “Outperform”. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) earned “Buy” rating by KeyBanc Capital Markets on Wednesday, September 6. The rating was maintained by Morgan Stanley with “Equal-Weight” on Monday, February 5. Barclays Capital maintained Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Thursday, February 8 with “Overweight” rating.

Since December 12, 2017, it had 1 buying transaction, and 40 sales for $49.86 million activity. Lennox James Patrick sold $375,571 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Thursday, March 1. 6,000 Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares with value of $478,981 were sold by fox John nelson JR. Breakiron-Evans Maureen also sold $1.66M worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Tuesday, March 6. Shares for $671,882 were sold by Mehta Rajeev. Frank Malcolm also sold $85,390 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares. Another trade for 774 shares valued at $64,798 was made by Shaheen Allen on Tuesday, March 13. Shares for $270,417 were sold by KRISHNASWAMY VENKAT.

Investors sentiment decreased to 0.97 in 2018 Q1. Its down 0.22, from 1.19 in 2017Q4. It dived, as 44 investors sold CTSH shares while 338 reduced holdings. 100 funds opened positions while 269 raised stakes. 491.22 million shares or 0.15% less from 491.94 million shares in 2017Q4 were reported. Dowling & Yahnke Ltd Limited Liability Company invested in 0.27% or 35,160 shares. 34,075 were accumulated by Peak6 Invests Ltd Partnership. Asset Mgmt One Limited has 948,567 shares. Jefferies Grp Llc invested in 72,724 shares or 0.03% of the stock. Pettee Investors holds 0.51% or 10,180 shares. First Merchants Corporation owns 30,148 shares for 0.41% of their portfolio. Optimum Investment Advsr has 0.11% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 4,715 shares. Farr Miller Washington Llc Dc has 2.97% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). First Interstate National Bank invested in 0.04% or 1,951 shares. 978,600 were accumulated by Factory Mutual. Whittier Tru Of Nevada reported 6,649 shares. Jane Street Ltd Company has 72,825 shares for 0.02% of their portfolio. Bailard stated it has 39,915 shares. Saratoga Rech Investment Mngmt has invested 4.72% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Cornerstone Advisors Inc, a Alabama-based fund reported 8,000 shares.

Another recent and important IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) news was published by Seekingalpha.com which published an article titled: “FDA OKs first non-opioid treatment for opioid withdrawal” on May 16, 2018.

Among 2 analysts covering Intellipharmaceutics Intl (NASDAQ:IPCI), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Intellipharmaceutics Intl had 9 analyst reports since December 31, 2015 according to SRatingsIntel. As per Tuesday, May 29, the company rating was maintained by H.C. Wainwright. The firm has “Buy” rating given on Tuesday, June 6 by Maxim Group. As per Thursday, December 31, the company rating was maintained by Maxim Group. The stock of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) earned “Buy” rating by H.C. Wainwright on Monday, February 12. Maxim Group maintained IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) rating on Friday, July 21. Maxim Group has “Buy” rating and $600 target. H.C. Wainwright maintained the stock with “Buy” rating in Monday, March 5 report. Maxim Group maintained it with “Buy” rating and $600 target in Friday, June 30 report. On Friday, February 16 the stock rating was downgraded by Maxim Group to “Hold”.

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and makes novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada. The company has market cap of $17.66 million. It develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. It currently has negative earnings. The companyÂ’s lead product is Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for attention deficit hyperactivity disorders.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>